Bone Biologics Corp 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Stockholders held on September 12, 2023. Bone Biologics Corporation (BBLG) is a Delaware corporation with its principal executive offices in Burlington, MA. The filing details the outcomes of five proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
Stockholders voted on the following matters at the Annual Meeting:
- Proposal 1 (Director Election): All four nominees (Don Hankey, Bruce Stroever, Erick Lucera, Siddhesh Angle) were elected. Each received approximately 1.21 million votes "For" with roughly 83,000 votes "Withheld."
- Proposal 2 (Say-on-Pay): Stockholders approved executive compensation on an advisory basis. Votes were 904,764 "For" versus 84,094 "Against."
- Proposal 3 (Say-on-Pay Frequency): Stockholders approved holding advisory compensation votes annually. Votes were 958,400 for "1 Year," 22,823 for "2 Years," and 2,726 for "3 Years."
- Proposal 4 (Auditor Ratification): Stockholders ratified the appointment of Weinberg & Company, P.A. as the independent registered public accounting firm for the fiscal year ending December 31, 2023. Votes were 1,513,051 "For" versus 61,316 "Against."
- Proposal 5 (Equity Plan Amendment): Stockholders approved the First Amendment to the 2015 Equity Incentive Plan. Votes were 863,931 "For" versus 123,150 "Against."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies. The Board of Directors adopted a policy to hold annual advisory votes on executive compensation based on the majority vote in Proposal 3.
Investor Verification Checklist
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Review the specific terms of the First Amendment to the 2015 Equity Incentive Plan approved in Proposal 5.
- Confirm the engagement letter and audit scope with Weinberg & Company, P.A. for the 2023 fiscal year.
- Check subsequent filings for the official appointment of the newly elected directors.